One of the most important principles of sound investment management is staying on top of what’s happening in the world and how those events affect finances. Conditions change quickly, and keeping up-to-date on developments and trends can be challenging. The team of experts producing IWB have been advising Canadian investors for over 25 years.
Edited and Published by Gordon Pape. Associate Editor: Richard Croft
With Gavin Graham, Ryan Irvine, Glenn Rogers, Shawn Allen, Adam Mayers, Paul Bamford & Michael Corcoran.
Recent Issues
iwb22403 (January 22, 2024)
Investing in small caps… The Week… Ryan Irvine updates Parkland Fuel, Sylogist Ltd., Trulieve Cannabis Corp… Smoothing the edges… Your Questions: Mortgage or TFSA… Members’ Corner: What do these terms mean?
iwb22402 (January 15, 2024)
Searching for dividends… The Week… Hidden assets drive McDonald’s profits… Adam Mayers updates fast-food giants… Gordon Pape updates UnitedHealth Group, Thermo Fisher Scientific… Gavin Graham updates First Quantum… S&P best in 2024?… Your Questions: Investing in Europe… Financial Factoids: Andrew Carnegie
iwb22401 (January 8, 2024)
Happy New Year… The Week… The year that was… Shawn Allen looks back and ahead… TransAlta: A stock for green investors… Shawn Allen updates Visa Inc., Toll Brothers… Gordon Pape updates Canadian Utilities, TFI International… Survey results… Your Questions: Betting it all on banks
iwb22344 (December 11, 2023)
And the winner is… The best performers of 2023… Two ways to invest in EVs… FedEx a big winner… Adam Mayers updates CAE, Horizons Active Global Dividend ETF… Gordon Pape updates Pfizer… Watch for survey… Price increase – final reminder
Recent Updates
Cameco Corp. (TSX: CCO, NYSE: CCJ)
Cameco is one of the world’s largest uranium producers, with mines at McArthur River and Cigar Lake in Saskatchewan and refineries in Ontario. As governments and investors have become more favourably inclined towards non-carbon emitting sources of baseload power such as nuclear in recent years, Cameco’s fortunes and its share price have revived.
Sell half
CGI Group (TSX: GIB.A, NYSE: GIB)
CGI is the fifth largest independent information technology and business process services firm in the world. The company, founded in 1976, delivers an end-to-end portfolio of capabilities, from IT and business consulting to systems integration, outsourcing services, and intellectual property solutions. It employs about 93,000 professionals in offices and delivery centres across the Americas, Europe, and the Asia Pacific region.
Hold
Bank of Nova Scotia (TSX, NYSE: BNS)
Scotiabank is the most internationally diversified of the major Canadian banks, with over 30% of its assets coming from its overseas operations, primarily what the bank describes as the three Pacific Alliance countries of Mexico, Peru, and Chile. It sold its subscale operations in Colombia, Panama, and Costa Rica to bank Davivienda in the first quarter in exchange for a 20% stake in Davivienda, taking a $1.4 billion impairment charge on the sale. Scotiabank has strengths in mortgage and corporate lending and wealth management and is usually the lowest cost operator amongst the major banks.
Buy
RBC Group (TSX, NYSE: RY)
RBC is the largest bank in Canada, with 23% market share after the acquisition of HSBC’s Canadian operations in late 2024. It has strengths in retail banking, investment banking, and asset management plus the largest share of mortgages and corporate lending in Canada.
Buy
Pfizer Inc. (NYSE: PFE)
Pfizer is a leading international pharmaceutical company that can trace its history back more than 170 years. Its business units include Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines, and Internal Medicine. Pfizer was the first company (along with partner BioNTech) to have a Covid vaccine approved for general use. It has proven to be highly effective with minimal side effects. The company has also developed a drug to treat the virus.